A detailed history of Bray Capital Advisors transactions in Mckesson Corp stock. As of the latest transaction made, Bray Capital Advisors holds 2,902 shares of MCK stock, worth $1.53 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
2,902
Previous 2,922 0.68%
Holding current value
$1.53 Million
Previous $1.71 Million 15.94%
% of portfolio
0.36%
Previous 0.44%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$479.06 - $630.38 $9,581 - $12,607
-20 Reduced 0.68%
2,902 $1.43 Million
Q2 2024

Jul 31, 2024

BUY
$518.81 - $607.81 $2,075 - $2,431
4 Added 0.14%
2,922 $1.71 Million
Q1 2024

Apr 30, 2024

BUY
$473.42 - $539.26 $1,420 - $1,617
3 Added 0.1%
2,918 $1.57 Million
Q4 2023

Jan 29, 2024

BUY
$437.42 - $470.64 $1,749 - $1,882
4 Added 0.14%
2,915 $1.35 Million
Q3 2023

Oct 27, 2023

BUY
$402.4 - $446.42 $1,609 - $1,785
4 Added 0.14%
2,911 $1.27 Million
Q2 2023

Jul 28, 2023

BUY
$354.01 - $427.31 $1,770 - $2,136
5 Added 0.17%
2,907 $1.24 Million
Q4 2022

Jan 20, 2023

SELL
$346.68 - $397.58 $147,339 - $168,971
-425 Reduced 12.77%
2,902 $0
Q1 2022

May 03, 2022

SELL
$244.61 - $310.48 $200,090 - $253,972
-818 Reduced 19.73%
3,327 $1.02 Million
Q4 2021

Jan 31, 2022

BUY
$198.21 - $248.9 $1,982 - $2,489
10 Added 0.24%
4,145 $1.03 Million
Q3 2020

Oct 30, 2020

BUY
$140.89 - $159.9 $582,580 - $661,186
4,135 New
4,135 $616,000
Q3 2019

Oct 29, 2019

SELL
$134.24 - $148.53 $218,140 - $241,361
-1,625 Closed
0 $0
Q4 2018

Feb 15, 2019

BUY
$108.23 - $136.84 $75,761 - $95,788
700 Added 75.68%
1,625 $180,000
Q3 2018

Oct 31, 2018

BUY
$123.14 - $138.52 $113,904 - $128,131
925 New
925 $123,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $75.6B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Bray Capital Advisors Portfolio

Follow Bray Capital Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bray Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Bray Capital Advisors with notifications on news.